hu6
Small moleculeexperimental
Clinical trial activity
10 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Aug 12, 2020 (NCT04463017)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07170189 | Phase 1 | Sep 30, 2025 | Rivus Pharmaceuticals, Inc. |
| NCT06486558 | Phase 1 | Jul 24, 2024 | Rivus Pharmaceuticals, Inc. |
| NCT06325930 | Phase 1 | Mar 26, 2024 | Rivus Pharmaceuticals, Inc. |
| NCT06104358 | Phase 2 | Nov 17, 2023 | Rivus Pharmaceuticals, Inc. |
| NCT05979779 | Phase 2 | Sep 5, 2023 | Rivus Pharmaceuticals, Inc. |
| NCT05284617 | Phase 2 | Oct 30, 2022 | Rivus Pharmaceuticals, Inc. |
| NCT05433506 | Phase 1 | Jul 15, 2022 | Nucleus Network Ltd, Rivus Pharmaceuticals, Inc. |
| NCT04874233 | Phase 2 | Apr 19, 2021 | Rivus Pharmaceuticals, Inc. |
| NCT04709913 | Phase 1 | Jan 4, 2021 | Prism Research, Rivus Pharmaceuticals, Inc. |
| NCT04463017 | Phase 1 | Aug 12, 2020 | Prism Research, Rivus Pharmaceuticals, Inc. |
Showing 10 of 10 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Rivus Pharmaceuticals, Inc. | For profit | 10 | 10 | 2 | 2020 |
| Prism Research | For profit | 2 | 0 | 1 | 2020 |
| Nucleus Network Ltd | For profit | 1 | 0 | 1 | 2022 |
3 organizations
Page 1 / 1